NCT00480896View on ClinicalTrials.gov

Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Dermatitis, Atopic
Interventions
DRUG

tacrolimus ointment

Topical application

DRUG

Placebo ointment

Topical application

Trial Locations (22)

Unknown

Brussels

Brno

3 Sites, Prague

Helsinki

Nantes

Paris

Düsseldorf

Frankfurt

Kiel

Mahlow

Budapest

Bergamo

Parma

Roma

Amsterdam

Groningen

Nijmegen

Utrecht

Porto

Barcelona

Birmingham

London

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00480896 - Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment | Biotech Hunter | Biotech Hunter